Glen Eagle Advisors, LLC Icad Inc Transaction History

Glen Eagle Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2024	SELL	$14.9 - $20.82 $13,261 - $18,529	-890 Closed	0 $0
Q4 2020 Aug 13, 2024	BUY	$8.73 - $14.56 $7,769 - $12,958	890 New	890 $11.7 Million
Q3 2020 Aug 13, 2024	BUY	$8.56 - $11.6 $856 - $1,160	100 Added 12.66%	890 $7.84 Million
Q2 2020 Aug 13, 2024	BUY	$6.63 - $12.85 $1,591 - $3,084	240 Added 43.64%	790 $7.89 Million
Q1 2020 Aug 13, 2024	BUY	$6.94 - $14.42 $3,817 - $7,931	550 New	550 $4.04 Million

5.48M

3.6K

14.6K

Ticker ICAD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 25,333,900
Market Cap $73.7M
Description
iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, an...

Get notified when there are updates to the investment portfolio of Glen Eagle Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Glen Eagle Advisors, LLC with notifications on news.